New Animal Drugs for Use in Animal Feeds; Chlortetracycline, 53966 [E6-15103]
Download as PDF
53966
Federal Register / Vol. 71, No. 177 / Wednesday, September 13, 2006 / Rules and Regulations
the right to make a unilateral filing with
FERC to modify this Agreement under
any applicable provision of the Federal
Power Act and FERC’s rules and
regulations; provided that each party
shall have the right to protest any such
filing by the other Party and to
participate fully in any proceeding
before FERC in which such
modifications may be considered.
Nothing in this Agreement shall limit
the rights of the parties or of FERC
under sections 205 or 206 of the Federal
Power Act and FERC’s rules and
regulations, except to the extent that the
parties otherwise agree as provided
herein.’’
Magalie R. Salas,
Secretary.
[FR Doc. E6–15126 Filed 9–12–06; 8:45 am]
BILLING CODE 6717–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 558
New Animal Drugs for Use in Animal
Feeds; Chlortetracycline
AGENCY:
Food and Drug Administration,
HHS.
Final rule, technical
amendment.
rmajette on PROD1PC67 with RULES1
ACTION:
SUMMARY: The Food and Drug
Administration (FDA) is amending the
animal drug regulations to reflect
approval of a supplemental new animal
drug application (NADA) filed by
Alpharma Inc. The supplemental NADA
provides for use of an approved Type A
medicated article containing
chlortetracycline to formulate a freechoice loose mineral Type C medicated
feed for beef and nonlactating dairy
cattle.
DATES: This rule is effective September
13, 2006.
FOR FURTHER INFORMATION CONTACT: Eric
S. Dubbin, Center for Veterinary
Medicine (HFV–126), Food and Drug
Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301–827–0232, email: eric.dubbin@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Alpharma
Inc., One Executive Dr., Fort Lee, NJ
07024, filed NADA 48–761 for use of
AUREOMYCIN 90 Granular
(chlortetracycline) Type A medicated
article to formulate a free-choice loose
mineral Type C medicated feed for beef
and nonlactating dairy cattle as an aid
in the control of active infection of
anaplasmosis caused by Anaplasma
VerDate Aug<31>2005
16:23 Sep 12, 2006
Jkt 208001
marginale susceptible to
chlortetracycline. The supplemental
NADA is approved as of July 28, 2006,
and the regulations are amended in 21
CFR 558.128 to reflect the approval. The
basis of approval is discussed in the
freedom of information summary.
In accordance with the freedom of
information provisions of 21 CFR part
20 and 21 CFR 514.11(e)(2)(ii), a
summary of safety and effectiveness
data and information submitted to
support approval of this application
may be seen in the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852, between 9
a.m. and 4 p.m., Monday through
Friday.
The agency has determined under 21
CFR 25.33(a)(1) that this action is of a
type that does not individually or
cumulatively have a significant effect on
the human environment. Therefore,
neither an environmental assessment
nor an environmental impact statement
is required.
This rule does not meet the definition
of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because
it is a rule of ‘‘particular applicability.’’
Therefore, it is not subject to the
congressional review requirements in 5
U.S.C. 801–808.
List of Subjects in 21 CFR Part 558
Animal drugs, Animal feeds.
I Therefore, under the Federal Food,
Drug, and Cosmetic Act and under
authority delegated to the Commissioner
of Food and Drugs and redelegated to
the Center for Veterinary Medicine, 21
CFR part 558 is amended as follows:
Ingredient
Percent
Cottonseed Meal
10.00
Trace Mineral/Vitamin
Premix1
Calcium Carbonate
3.80
Dried Cane Molasses
3.00
Potassium Chloride
2.00
Mineral Oil
2.00
Iron Oxide
0.50
Chlortetracycline Type A
medicated article (90
gram/lb)
International
Feed No.
3.33
3.50
5–01–
625
6–01–
069
4–04–
695
6–03–
755
8–03–
123
6–02–
431
1Content of vitamin and trace mineral premixes may be varied. However, they should
be comparable to those used for other freechoice feeds. Formulation modifications require FDA approval prior to marketing. Selenium must comply with 21 CFR 573.920.
Ethylenediamine dihydroiodide (EDDI) should
comply with FDA Compliance Policy Guides
Sec. 651.100 (CPG 7125.18).
(ii) Amount. 6,000 grams per ton.
(iii) Indications for use. Beef and
nonlactating dairy cattle: As an aid in
the control of active infection of
anaplasmosis caused by Anaplasma
marginale susceptible to
chlortetracycline.
(iv) Limitations. Feed continuously on
a free-choice basis at a rate of 0.5 to 2.0
mg chlortetracycline per head per day.
(v) Sponsor. See No. 046573 in
§ 510.600(c) of this chapter.
*
*
*
*
*
PART 558—NEW ANIMAL DRUGS FOR
USE IN ANIMAL FEEDS
1. The authority citation for 21 CFR
part 558 continues to read as follows:
Dated: August 30, 2006.
Steven D. Vaughn,
Director, Office of New Animal Drug
Evaluation, Center for Veterinary Medicine.
[FR Doc. E6–15103 Filed 9–12–06; 8:45 am]
BILLING CODE 4160–01–S
I
Authority: 21 U.S.C. 360b, 371.
2. In § 558.128, redesignate paragraph
(e)(6) as paragraph (e)(7); and add new
paragraph (e)(6) to read as follows:
DEPARTMENT OF THE TREASURY
§ 558.128
26 CFR Part 54
I
Chlortetracycline.
*
*
*
*
*
(e) * * *
(6) It is used as a free-choice, loose
mineral Type C feed as follows:
(i) Specifications.
Ingredient
Percent
Dicalcium Phosphate
46.20
Sodium Chloride (Salt)
15.00
Magnesium Oxide
10.67
PO 00000
Frm 00004
Fmt 4700
Sfmt 4700
International
Feed No.
6–26–
335
6–04–
152
6–02–
756
Internal Revenue Service
[TD 9277]
RIN 1545–BE30
Employer Comparable Contributions to
Health Savings Accounts Under
Section 4980G; Correction
Internal Revenue Service (IRS),
Treasury.
ACTION: Correcting amendment.
AGENCY:
SUMMARY: This document contains a
correction to final regulations (TD 9277)
that were published in the Federal
E:\FR\FM\13SER1.SGM
13SER1
Agencies
[Federal Register Volume 71, Number 177 (Wednesday, September 13, 2006)]
[Rules and Regulations]
[Page 53966]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-15103]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 558
New Animal Drugs for Use in Animal Feeds; Chlortetracycline
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule, technical amendment.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of a supplemental new animal drug
application (NADA) filed by Alpharma Inc. The supplemental NADA
provides for use of an approved Type A medicated article containing
chlortetracycline to formulate a free-choice loose mineral Type C
medicated feed for beef and nonlactating dairy cattle.
DATES: This rule is effective September 13, 2006.
FOR FURTHER INFORMATION CONTACT: Eric S. Dubbin, Center for Veterinary
Medicine (HFV-126), Food and Drug Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301-827-0232, e-mail: eric.dubbin@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Alpharma Inc., One Executive Dr., Fort Lee,
NJ 07024, filed NADA 48-761 for use of AUREOMYCIN 90 Granular
(chlortetracycline) Type A medicated article to formulate a free-choice
loose mineral Type C medicated feed for beef and nonlactating dairy
cattle as an aid in the control of active infection of anaplasmosis
caused by Anaplasma marginale susceptible to chlortetracycline. The
supplemental NADA is approved as of July 28, 2006, and the regulations
are amended in 21 CFR 558.128 to reflect the approval. The basis of
approval is discussed in the freedom of information summary.
In accordance with the freedom of information provisions of 21 CFR
part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and
effectiveness data and information submitted to support approval of
this application may be seen in the Division of Dockets Management
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.
The agency has determined under 21 CFR 25.33(a)(1) that this action
is of a type that does not individually or cumulatively have a
significant effect on the human environment. Therefore, neither an
environmental assessment nor an environmental impact statement is
required.
This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements
in 5 U.S.C. 801-808.
List of Subjects in 21 CFR Part 558
Animal drugs, Animal feeds.
0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is
amended as follows:
PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
0
1. The authority citation for 21 CFR part 558 continues to read as
follows:
Authority: 21 U.S.C. 360b, 371.
0
2. In Sec. 558.128, redesignate paragraph (e)(6) as paragraph (e)(7);
and add new paragraph (e)(6) to read as follows:
Sec. 558.128 Chlortetracycline.
* * * * *
(e) * * *
(6) It is used as a free-choice, loose mineral Type C feed as
follows:
(i) Specifications.
------------------------------------------------------------------------
Ingredient Percent International Feed No.
------------------------------------------------------------------------
Dicalcium Phosphate 46.20 6-26-335
Sodium Chloride (Salt) 15.00 6-04-152
Magnesium Oxide 10.67 6-02-756
Cottonseed Meal 10.00 5-01-625
Trace Mineral/Vitamin 3.80 .......................
Premix\1\
Calcium Carbonate 3.50 6-01-069
Dried Cane Molasses 3.00 4-04-695
Potassium Chloride 2.00 6-03-755
Mineral Oil 2.00 8-03-123
Iron Oxide 0.50 6-02-431
Chlortetracycline Type A 3.33 .......................
medicated article (90 gram/
lb)
------------------------------------------------------------------------
\1\Content of vitamin and trace mineral premixes may be varied. However,
they should be comparable to those used for other free-choice feeds.
Formulation modifications require FDA approval prior to marketing.
Selenium must comply with 21 CFR 573.920. Ethylenediamine
dihydroiodide (EDDI) should comply with FDA Compliance Policy Guides
Sec. 651.100 (CPG 7125.18).
(ii) Amount. 6,000 grams per ton.
(iii) Indications for use. Beef and nonlactating dairy cattle: As
an aid in the control of active infection of anaplasmosis caused by
Anaplasma marginale susceptible to chlortetracycline.
(iv) Limitations. Feed continuously on a free-choice basis at a
rate of 0.5 to 2.0 mg chlortetracycline per head per day.
(v) Sponsor. See No. 046573 in Sec. 510.600(c) of this chapter.
* * * * *
Dated: August 30, 2006.
Steven D. Vaughn,
Director, Office of New Animal Drug Evaluation, Center for Veterinary
Medicine.
[FR Doc. E6-15103 Filed 9-12-06; 8:45 am]
BILLING CODE 4160-01-S